Amplexd Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Amplexd Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities (NCT07572396) | Amplexd Therapeutics, Inc. | 2026-04-30 |
Track Amplexd Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.